Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Swedish (OMX) Pharma Industry Analysis

UpdatedApr 27, 2025
DataAggregated Company Financials
Companies27
  • 7D3.5%
  • 3M-2.2%
  • 1Y1.1%
  • YTD-5.1%

Over the last 7 days, the Pharma industry has risen 3.5%, driven by gains from Camurus of 4.1%. During this same period, the AcuCort underperformed, falling 9.1%. The industry has been flat over the past 12 months despite the gain this week. Looking forward, earnings are forecast to grow by 50% annually.

Industry Valuation and Performance

Has the Swedish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 27 Apr 2025SEK 49.1bSEK 4.8b-SEK 917,745,943.1971.1x-53.5x10.3x
Tue, 25 Mar 2025SEK 52.5bSEK 4.7b-SEK 809,348,956.3375x-64.8x11.2x
Thu, 20 Feb 2025SEK 54.0bSEK 4.7b-SEK 796,512,649.5788.4x-67.8x11.5x
Sat, 18 Jan 2025SEK 50.2bSEK 4.4b-SEK 580,988,455.36125.5x-86.4x11.3x
Mon, 16 Dec 2024SEK 49.7bSEK 4.4b-SEK 615,883,468.75129.8x-80.8x11.2x
Wed, 13 Nov 2024SEK 52.5bSEK 4.4b-SEK 639,905,315.27129.1x-82x11.8x
Fri, 11 Oct 2024SEK 64.8bSEK 5.9b-SEK 1,157,189,987.12171.2x-56x11x
Sun, 08 Sep 2024SEK 67.8bSEK 5.9b-SEK 1,170,139,603.50176.9x-58x11.5x
Tue, 06 Aug 2024SEK 64.7bSEK 5.6b-SEK 992,815,736.3090.5x-65.2x11.6x
Thu, 04 Jul 2024SEK 65.7bSEK 6.4b-SEK 862,422,912.8076.3x-76.2x10.3x
Sat, 01 Jun 2024SEK 60.2bSEK 6.4b-SEK 766,392,647.4174.3x-78.6x9.5x
Mon, 29 Apr 2024SEK 48.6bSEK 6.3b-SEK 950,949,196.2765.4x-51.1x7.7x
Wed, 27 Mar 2024SEK 52.9bSEK 6.2b-SEK 1,038,115,045.0777.1x-50.9x8.5x
Fri, 23 Feb 2024SEK 46.8bSEK 6.2b-SEK 1,038,807,098.4582.5x-45x7.5x
Sun, 21 Jan 2024SEK 68.2bSEK 9.5b-SEK 1,182,202,468.0062.3x-57.7x7.2x
Tue, 19 Dec 2023SEK 66.4bSEK 9.4b-SEK 1,184,273,661.0061.9x-56.1x7x
Thu, 16 Nov 2023SEK 58.4bSEK 9.5b-SEK 1,230,435,744.0095.5x-47.5x6.2x
Sat, 14 Oct 2023SEK 50.9bSEK 9.2b-SEK 1,181,413,707.00101.4x-43.1x5.5x
Mon, 11 Sep 2023SEK 50.8bSEK 9.2b-SEK 1,177,925,858.00137.5x-43.1x5.5x
Wed, 09 Aug 2023SEK 51.6bSEK 8.9b-SEK 1,396,149,866.0085.7x-36.9x5.8x
Fri, 07 Jul 2023SEK 48.1bSEK 8.4b-SEK 1,693,639,315.0073.7x-28.4x5.7x
Sun, 04 Jun 2023SEK 47.9bSEK 8.4b-SEK 1,608,786,861.0076.5x-29.8x5.7x
Tue, 02 May 2023SEK 47.1bSEK 8.1b-SEK 1,817,383,597.0096.9x-25.9x5.8x
Thu, 30 Mar 2023SEK 44.4bSEK 8.0b-SEK 1,793,688,371.0084.7x-24.7x5.6x
Sat, 25 Feb 2023SEK 44.5bSEK 8.0b-SEK 1,845,412,023.00221.7x-24.1x5.5x
Mon, 23 Jan 2023SEK 48.9bSEK 7.3b-SEK 1,938,336,904.00278.2x-25.2x6.7x
Wed, 21 Dec 2022SEK 48.7bSEK 7.3b-SEK 1,910,539,837.00276.3x-25.5x6.7x
Fri, 18 Nov 2022SEK 48.9bSEK 7.1b-SEK 1,904,685,165.0049.4x-25.7x6.8x
Sun, 16 Oct 2022SEK 49.3bSEK 7.0b-SEK 1,754,682,602.0047x-28.1x7.1x
Tue, 13 Sep 2022SEK 52.4bSEK 7.0b-SEK 1,737,055,214.0055.1x-30.1x7.5x
Thu, 11 Aug 2022SEK 53.7bSEK 6.9b-SEK 1,535,730,526.0041.8x-34.9x7.8x
Sat, 09 Jul 2022SEK 54.8bSEK 5.9b-SEK 1,509,116,648.0041.9x-36.3x9.3x
Mon, 06 Jun 2022SEK 54.2bSEK 5.9b-SEK 1,505,666,101.0044.6x-36x9.1x
Wed, 04 May 2022SEK 52.9bSEK 5.5b-SEK 1,351,308,728.0036.9x-39.2x9.6x
Price to Earnings Ratio

-39.2x


Total Market Cap: SEK 52.9bTotal Earnings: -SEK 1,351,308,728.00Total Revenue: SEK 5.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Pharma Industry Price to Earnings3Y Average -47.5x202320242025
Current Industry PE
  • Investors are optimistic on the Swedish Pharmaceuticals industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 8.2x is lower than the industry's current PS ratio of 10.3x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 4.9% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the Swedish Healthcare industry?

SE Market3.42%
Healthcare3.47%
Pharma3.45%
Pharma3.45%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
CAMX CamurusSEK 589.004.1%
+SEK 1.3b		20.2%PE80.6x
DICOT Dicot PharmaSEK 0.3422.9%
+SEK 128.6m		38.7%PB6.2x
IBT B Infant Bacterial TherapeuticsSEK 53.205.3%
+SEK 36.4m		-39.4%PS179169.9x
CESSA CessatechDKK 12.6411.1%
+DKK 22.0m		90.9%PS88.6x
FLERIE FlerieSEK 40.600.9%
+SEK 26.9m		n/aPS7922.8x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

SECARE

SEK 35.75

Swedencare

7D

0.4%

1Y

-35.0%

IBT B

SEK 53.20

Infant Bacterial Therapeutics

7D

5.3%

1Y

-39.4%

ACUC

SEK 0.69

AcuCort

7D

-9.1%

1Y

23.4%

CESSA

DKK 12.64

Cessatech

7D

11.1%

1Y

90.9%

ENZY

SEK 3.50

Enzymatica

7D

2.0%

1Y

13.6%

NEWBRY

SEK 3.29

Newbury Pharmaceuticals

7D

-3.2%

1Y

-3.5%

KLAR

SEK 1.15

Klaria Pharma Holding AB (publ.)

7D

-0.4%

1Y

249.5%

MOB

SEK 8.11

Moberg Pharma

7D

5.3%

1Y

-75.6%

author-image

Norway Expansion And EU Approvals Will Strengthen Future Position

Apr 13 Expansion in Norway and obtaining EU approvals bolster revenue potential and support Moberg Pharma's European growth strategy.

ONCOZ

SEK 4.65

OncoZenge

7D

-2.0%

1Y

19.4%

ALZCUR

SEK 2.31

AlzeCure Pharma

7D

-6.5%

1Y

14.4%

FLERIE

SEK 40.60

Flerie

7D

0.9%

1Y

n/a

KDEV

SEK 0.92

Karolinska Development

7D

-2.0%

1Y

-41.4%

DICOT

SEK 0.34

Dicot Pharma

7D

22.9%

1Y

38.7%

PILA

SEK 3.19

Pila Pharma

7D

-7.9%

1Y

38.7%

CAMX

SEK 589.00

Camurus

7D

4.1%

1Y

20.2%

Camurus AB (publ)'s (STO:CAMX) Popularity With Investors Is Under Threat From Overpricing

Mar 09
Camurus AB (publ)'s (STO:CAMX) Popularity With Investors Is Under Threat From Overpricing

ODI

SEK 2.58

ODI Pharma

7D

-3.7%

1Y

-54.7%